Suppr超能文献

社区环境下的成功医学减重

Successful Medical Weight Loss in a Community Setting.

作者信息

Carney Douglas, Schultz Stephen, Lim Jeong, Walters William

机构信息

Weight Management Program, Salem, Oregon, USA.

Health & Nutrition Technology Inc., Carmel, California, USA.

出版信息

J Obes Weight Loss Ther. 2015 Feb;5(1). doi: 10.4172/2165-7904.1000248. Epub 2015 Feb 27.

Abstract

BACKGROUND

Research has shown that meal replacement calorie reduction combined with lifestyle change can more than double the weight loss seen with other diets. However, its widespread acceptance by physicians has been limited, perhaps waiting on evidence that patients are successful in keeping lost weight off.

METHODS

Obese patients (108.4 ± 25.7 kg, BMI 38.1 ± 7.9 kg/m) used a diet of meal replacements combined with weekly classes. While learning about nutrition, exercise, and accountability, patients tracked calorie intake and physical activity. Weight loss and retention rates for rapid weight loss and maintenance phases were measured. Weights then obtained years after treatment ended showed that patients were keeping lost weight off without any ongoing clinic intervention.

RESULTS

Records of 714 patients treated in a medical weight loss practice from 2004 through 2012 were reviewed. For all patients, weight loss was 13.6 ± 8.3 kg, and 12.5% of initial weight. The 469 patients who completed 16 weeks of weight loss classes lost 16.7 ± 7.2 kg and 15.1%. 433 patients then enrolled in maintenance classes, and after 12 months had regained only 0.1 ± 9.1 kg and 0.4%. Follow up weights obtained from 173 patients more than 2 years after treatment ended showed persisting weight loss of 14.3 ± 13.7 kg and 12.9%. Final BMI was 32.7 ± 7.7 kg/m.

CONCLUSION

In a medical weight loss program that used meal replacements to reduce calorie intake combined with weekly behavior change classes, weight loss was 16.2 kg and 14.4% for the 61% of all enrollees who completed 16 months of treatment. More importantly, over 2 years later, weight loss of 14.3 kg and 12.9% of initial weight persisted, and patients were not regaining their lost weight.

摘要

背景

研究表明,代餐热量减少并结合生活方式改变,其减重效果比其他饮食方式高出一倍多。然而,医生对其广泛接受程度有限,可能是在等待患者成功维持减重效果的证据。

方法

肥胖患者(体重108.4±25.7千克,体重指数38.1±7.9千克/平方米)采用代餐饮食并参加每周课程。在学习营养、运动和责任相关知识时,患者记录卡路里摄入量和身体活动情况。测量快速减重和维持阶段的减重及体重维持率。治疗结束数年后获取的体重数据显示,患者在没有任何持续临床干预的情况下保持了减重效果。

结果

回顾了2004年至2012年在一家医学减重机构接受治疗的714例患者的记录。所有患者的体重减轻了13.6±8.3千克,占初始体重的12.5%。完成16周减重课程的469例患者体重减轻了16.7±7.2千克,占15.1%。433例患者随后参加维持课程,12个月后仅增重0.1±9.1千克,占0.4%。治疗结束2年多后从173例患者处获取的随访体重显示,持续减重14.3±13.7千克,占12.9%。最终体重指数为32.7±7.7千克/平方米。

结论

在一个使用代餐减少卡路里摄入并结合每周行为改变课程的医学减重项目中,完成16个月治疗的所有入组患者中有61%的体重减轻了16.2千克,占14.4%。更重要的是,2年多后,体重减轻了14.3千克,占初始体重的12.9%,且患者没有恢复到原来的体重。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9292/4657754/5c9e97429b3a/nihms720501f1.jpg

相似文献

1
Successful Medical Weight Loss in a Community Setting.
J Obes Weight Loss Ther. 2015 Feb;5(1). doi: 10.4172/2165-7904.1000248. Epub 2015 Feb 27.
3
Meal replacements as a strategy for weight loss in obese hemodialysis patients.
Hemodial Int. 2016 Oct;20(4):E18-E23. doi: 10.1111/hdi.12419. Epub 2016 Apr 4.
4
A comparison of meal replacements and medication in weight maintenance after weight loss.
J Am Coll Nutr. 2005 Oct;24(5):347-53. doi: 10.1080/07315724.2005.10719484.
5
Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
Obesity (Silver Spring). 2007 Jun;15(6):1464-72. doi: 10.1038/oby.2007.175.
8
Do meal replacement drinks have a role in diabetes management?
Nestle Nutr Workshop Ser Clin Perform Programme. 2006;11:171-181. doi: 10.1159/000094450.

引用本文的文献

1
Expert Coaching in Weight Loss: Retrospective Analysis.
J Med Internet Res. 2018 Mar 13;20(3):e92. doi: 10.2196/jmir.9738.

本文引用的文献

2
Effects of low-carbohydrate and low-fat diets: a randomized trial.
Ann Intern Med. 2014 Sep 2;161(5):309-18. doi: 10.7326/M14-0180.
3
A call for an end to the diet debates.
JAMA. 2013 Aug 21;310(7):687-8. doi: 10.1001/jama.2013.8601.
4
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.
N Engl J Med. 2013 Jul 11;369(2):145-54. doi: 10.1056/NEJMoa1212914. Epub 2013 Jun 24.
5
Treating diabetes with surgery.
JAMA. 2013 Jun 5;309(21):2274-5. doi: 10.1001/jama.2013.4772.
6
Scientific decision making, policy decisions, and the obesity pandemic.
Mayo Clin Proc. 2013 Jun;88(6):593-604. doi: 10.1016/j.mayocp.2013.04.005.
7
Myths, presumptions, and facts about obesity.
N Engl J Med. 2013 Jan 31;368(5):446-54. doi: 10.1056/NEJMsa1208051.
8
Leading avoidable cause of premature deaths worldwide: case for obesity.
Am J Med. 2013 Feb;126(2):97-8. doi: 10.1016/j.amjmed.2012.06.018.
9
Progress in obesity research: reasons for optimism.
JAMA. 2012 Sep 19;308(11):1162-4. doi: 10.1001/2012.jama.12203.
10
FDA approval of obesity drugs: a difference in risk-benefit perceptions.
JAMA. 2012 Sep 19;308(11):1097-8. doi: 10.1001/jama.2012.10007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验